Healthcare It News

JANUARY 18, 2022

Care managers and social workers, working within accountable care organizations, and physician provider networks now incorporate a short series of SDOH interview questions with patients identified as high-risk for poor healthcare outcomes or unnecessary future healthcare expenditures.

Pharmaceuticals 346

Pharmaceuticals Accountable Care Accountability Medicaid 346

Bill Of Health

OCTOBER 28, 2022

The selections feature topics ranging from an examination of Park doctrine prosecutions of executives of pharmaceutical and medical device companies, an analysis of patent thickets covering biologic drugs, and a discussion of product hopping strategies among manufacturers of inhalers. The Political Economy of Market Power in Pharmaceuticals.

Pharmaceuticals 96

Pharmaceuticals Regulations Accountability Medicaid 96

Healthcare ECONOMIST

DECEMBER 17, 2023

The share of the economy accounted for by the health sector was 17.3 Pharmaceutical spending as a share of total health care spending has been relatively constant at around 9% throughout the past 7 years. The insured share of the population reached a historic high of 92.0 percent in 2022, which was down from a peak of 19.5

Pharmaceuticals 96

Pharmaceuticals Medicaid Accountability 96

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

HIT Consultant

APRIL 15, 2024

In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. They are also in communication with the sponsor, who is the MAH of the active pharmaceutical ingredient. In comparison to Japan, China has fewer distinctions.

Pharmaceuticals 96

Pharmaceuticals Patient Safety Accountability Integration 96

Bill Of Health

OCTOBER 26, 2023

However, the deep wounds of the pandemic remain, compelling those concerned about this pandemic and future health emergencies to account for catastrophic failures by those in power. That has created deep inequities in access to health products that can save lives.

Accountability 119

Accountability Prevention Pharmaceuticals Regulations 119

Healthcare ECONOMIST

AUGUST 1, 2022

For large publicly traded pharmaceutical firms, research and other costs are public on their financial statements. It may appear on financial statements that successful pharmaceutical make outsized profits, but these figures must also take into account that many pharmaceutical firms have drugs that fail and the companies go out of business.

Pharmaceuticals 68

Pharmaceuticals Biotechnology Accountability 68

Healthcare ECONOMIST

MARCH 22, 2022

Based on analysis from National Income and Product Accounts (NIPAs), multifactor productivity (MFP) in the health care and social assistance sector declined by 0.4% Another issue is that in national accounts, each provider type (e.g., hospitals, physicians, pharmaceuticals) is treated as a separate industry. increase in MFP.

Pharmaceuticals 67

Pharmaceuticals Accountability Medicare Hospitals 67

HIT Consultant

SEPTEMBER 26, 2022

The new normal has thrown up opportunities as well as risks for pharmaceutical companies. Nevertheless, there is a downward trend in the consumption of prescription medicine due to lower spending, apart from increased competition from generics and rising instances of pharmaceutical fraud and counterfeiting that lead to consumer distrust (2).

Life Sciences 97

Life Sciences Pharmaceuticals Telemedicine Healthcare Providers 97

Bill Of Health

DECEMBER 27, 2021

Engaging parameters,” accountability and benefit , redirect attention from those who experience injustice to those who contribute to or enjoy from the status quo. While the engagement of the UN , WHO , or governments is obvious, the accountability parameter may also engage other stakeholders to sit at the table.

Accountability 104

Accountability Pharmaceuticals Regulations Prevention 104

Bill Of Health

DECEMBER 12, 2023

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.

Pharmaceuticals 57

Pharmaceuticals Accountability Regulations Prevention 57

Healthcare ECONOMIST

OCTOBER 19, 2023

However, CEAs in the past have rarely accounted for these possibilities and instead assume that a drug’s price remains constant over time. A static drug pricing assumption fails to account for anticipated savings from the genericization of the alternative treatment.

Pharmaceuticals 71

Pharmaceuticals Accountability 71

HIT Consultant

AUGUST 16, 2023

This technology enables pharmaceutical and biotech customers to consider decentralized and hybrid clinical trial strategies in study protocols that would have otherwise been limited to on-site evaluations.

Pharmaceuticals 52

Pharmaceuticals Accountability Integration Life Sciences 52

Bill Of Health

DECEMBER 22, 2023

Pharmaceutical companies should consider adopting an “access by design” approach, i.e., embedding fairer and equitable access to intellectual property at all stages of drug development and deployment. One way forward that was discussed was a collaborative and voluntary mechanism.

Pharmaceuticals 62

Pharmaceuticals Accountability Doctors Hospitals 62

Healthcare ECONOMIST

JUNE 13, 2022

Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. Clinical trial costs account for 94% of the total investment, with manufacturing costs accounting for only 6%. A study by Ahuja et al. trillion in social value. per annum and a net present value of –$9.5

Life Sciences 83

Life Sciences Pharmaceuticals Accountability Prevention 83

Sheppard Health Law

JULY 10, 2023

On June, 23, 2023, New York City Mayor Eric Adams signed the Healthcare Accountability and Consumer Protection Act ( Intro. This local law amends the New York City Charter and directs the Mayor to establish an Office of Healthcare Accountability – the first of its kind in the country.

Accountability 52

Accountability Pharmaceuticals Hospitals Medicaid 52

HIT Consultant

AUGUST 15, 2011

The second part interview where Host, Gina Clark, Chief Marketing Officer for AmerisourceBergen interviews Loreen Brown, VP of Access and Reimbursement for Xcenda to share her insights on the impact of Accountable Care Organizations on healthcare delivery. For more information, visit amerisourcebergen.com.

Accountable Care 52

Accountable Care Accountability Pharmaceuticals Healthcare 52

Healthcare ECONOMIST

FEBRUARY 19, 2024

Casgevy” from Vertex Pharmaceuticals and CRISPR Therapeutics had a list price of $2.2 Note that the patient outcome rebates can be paid annually over time to account for cases where patients respond to therapy but perhaps not indefinitely. Two CGTs for the treatment of sickle cell disease are planned for inclusion in the model.

Medicaid 110

Medicaid Pharmaceuticals Accountability 110

HIT Consultant

JUNE 18, 2024

What You Should Know: – Mika Health , a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo. million new cases were diagnosed, accounting for one in four new cancer cases.

Pharmaceuticals 52

Pharmaceuticals Regulations Accountability Life Sciences 52

Healthcare ECONOMIST

SEPTEMBER 20, 2021

To account for rebates in the US they use SSR Health information Then international prices are identified based on the IQVIA MIDAS data across 6 markets (Australia, Canada, France, Germany, Japan, and the U.K). The authors use IQVIA MIDAS data to estimate sales price and volume in the US. Title II of H.R.

Pharmaceuticals 90

Pharmaceuticals Life Sciences Accountability 90

HIT Consultant

OCTOBER 20, 2023

According to a study in the Journal of the American Geriatric Society , non-fatal falls cost an estimated $50 billion in medical expenses, while fatal falls account for an estimated $754 million. Prior to Dominion, Dr. Fornari was a research scientist and consultant to the pharmaceutical industry. It is also an expensive problem.

Rehabilitation 105

Rehabilitation Pharmaceuticals Prevention Biotechnology 105

Healthcare ECONOMIST

APRIL 2, 2024

One key question is what factors do US payers take into account when evaluating DTx and how does that differ from standard pharmaceuticals. A paper by Gomez Lumbreras et al. 2024) held virtual focus groups with 21 US payers to find the answer. Key considerations include: Need for Evidence.

Pharmaceuticals 68

Pharmaceuticals Regulations Accountability Prevention 68

HIT Consultant

MAY 2, 2022

The pharmaceutical industry differs in many ways from other industries. Along this entire path, the organization must ensure that diverse voices are included and the needs of diverse patient populations are taken into account. Diversity needs to become part of the fabric of pharmaceutical companies and the industry as a whole.

Life Sciences 98

Life Sciences Pharmaceuticals Healthcare Providers Healthcare 98

HIT Consultant

AUGUST 5, 2022

Supply costs are often less significant in the cost structure of PPM companies, and campaigns run by large drug companies in an effort to increase market share for pharmaceuticals coming off patent expiration may generate additional opportunities for PPM companies to achieve higher margins on J-Code drug billing.

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

Bill Of Health

MARCH 1, 2024

Although Grossbard and Bourzat deny the allegations, these accounts were vetted by leading news organizations, withstood legal threats from Grossbard and Bourzat, and have been substantiated by a growing body of consistent and corroborated accounts by survivors.

Accountability 108

Accountability Biotechnology Rehabilitation Regulations 108

HIT Consultant

AUGUST 30, 2023

AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs. Ensuring transparency, accountability, and patient autonomy must be prioritized.

Healthcare 111

Healthcare Pharmaceuticals Medical Technology Medical Practitioners 111

Healthcare ECONOMIST

MAY 18, 2022

As summarized an ISPOR’s Value and Outcomes Spotlight article titled “ Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration? What considerations beyond quality adjusted life years and cost should be considered when evaluating gene therapies? A panel from ISPOR provided just such a discussion.

Pharmaceuticals 66

Pharmaceuticals Accountability 66

HIT Consultant

APRIL 8, 2024

The healthcare segment accounted for 20% of that market share in 2022. As some cultures are hesitant to use conventional pharmaceuticals, VR technology could offer a viable alternative for patients experiencing physical distress. According to Global Market Insights, the machine translation market size was valued at 982.2

Healthcare Providers 105

Healthcare Providers Pharmaceuticals Healthcare Accountability 105

Bill Of Health

NOVEMBER 7, 2023

Yet when COVID-19 – the greatest health emergency in a century – devastated the world, the Siracusa Principles seemed unequal to the task – too narrow, including with their remit limited to civil and political rights, not sufficiently specific, and above all, without sufficient accountability.

Accountability 113

Accountability Regulations Medical Technology Pharmaceuticals 113

HIT Consultant

MAY 22, 2023

Though there is a vast level of chemical space to foster the development of drug molecules, a lack of advanced technologies can limit the traditional drug development process, making it time consuming and expensive for pharmaceutical and biotech companies to pursue. What are some of the varying systematic approaches to repurposing?

Pharmaceuticals 96

Pharmaceuticals Accountability Integration Life Sciences 96

Bill Of Health

JANUARY 18, 2024

Without adequate guidance for how to comply with human rights in the context of public health emergencies, the authors therefore noted that States commonly “exceeded permissible derogations from the ICCPR” and faced “little accountability for their actions whether on domestic or international levels.” Ahmed et al.

Regulations 108

Regulations Prevention Accountability Pharmaceuticals 108

Healthcare ECONOMIST

DECEMBER 13, 2021

The key findings from the article are: HTA practices are designed to be used for medical technologies and pharmaceuticals that treat commonly-occurring diseases, and are not fit to determine the value of orphan drugs for rare disease, which face unique challenges. That is a title of a new white paper from FTI Consulting and Alexion.

Medical Technology 63

Medical Technology Pharmaceuticals Accountability 63

NCQA

MARCH 20, 2024

It explores best practices for: Building equitable partnerships: Ensuring power dynamics are fair and accountability is shared. NCQA thanks Takeda Pharmaceuticals U.S.A., Developing mutually beneficial agreements: Creating collaboration that leverages strengths of each organization. for sponsoring this integrated, instructive work.

Pharmaceuticals 52

Pharmaceuticals Accountability Integration Hospitals 52

GoMoHealth

FEBRUARY 9, 2022

He graduated Rutgers College with degrees in business, accounting and art history. After graduation, he worked as an accountant for Deloitte, Haskins & Sells, and then as an advertising executive with Tracy Locke/ BBDO, before founding his own advertising agency, Krampf Communications in 1981.

Life Sciences 88

Life Sciences Healthcare Accountability Pharmaceuticals 88

HIT Consultant

FEBRUARY 28, 2024

The Centers for Disease Control and Prevention estimates that obesity accounts for $147 billion in annual healthcare costs, an amount which could be greatly lowered through use of the new drugs. But that will almost certainly happen as more pharmaceutical companies enter this market and the economies of scale take hold.

Patient Experience 98

Patient Experience Doctors Pharmaceuticals Nursing 98

Bill Of Health

JUNE 12, 2023

Finally, at the advanced pharmaceutical manufacturing stage , AI/ML is being used to optimize process design (e.g., At the postmarketing safety surveillance stage , AI/ML is helping automate the processing of individual case safety reports (ICSRs), the evaluation of cases (e.g.,

Pharmaceuticals 104

Pharmaceuticals Accountability Biotechnology Regulations 104

Healthcare Leadership Council

MAY 25, 2023

Erin Geygan, senior privacy counsel at Johnson & Johnson, explained that the organization is comprised of three segments – pharmaceutical, medtech and consumer health, which have invested $14.6 billion in research and development.

Healthcare Innovation 40

Healthcare Innovation Healthcare Life Sciences Rehabilitation 40